HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frans J Walther Selected Research

Right Ventricular Hypertrophy

1/2017Bone Morphogenetic Protein 9 Protects against Neonatal Hyperoxia-Induced Impairment of Alveolarization and Pulmonary Inflammation.
8/2015Metformin attenuates hyperoxia-induced lung injury in neonatal rats by reducing the inflammatory response.
8/2014Angiotensin II type 2 receptor ligand PD123319 attenuates hyperoxia-induced lung and heart injury at a low dose in newborn rats.
9/2013Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury.
2/2013Ambrisentan reduces pulmonary arterial hypertension but does not stimulate alveolar and vascular development in neonatal rats with hyperoxic lung injury.
1/2012Phosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in rats.
11/2010Apelin attenuates hyperoxic lung and heart injury in neonatal rats.
4/2009Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frans J Walther Research Topics

Disease

17Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2022 - 12/2002
14Hyperoxia
01/2018 - 03/2004
14Lung Injury
01/2018 - 11/2004
10Bronchopulmonary Dysplasia
01/2022 - 04/2006
9Lung Diseases (Lung Disease)
01/2017 - 04/2006
8Right Ventricular Hypertrophy
01/2017 - 04/2009
8Pneumonia (Pneumonitis)
01/2017 - 07/2007
8Inflammation (Inflammations)
08/2015 - 11/2004
8Fetofetal Transfusion (Twin Transfusion Syndrome)
06/2014 - 11/2005
6Infections
12/2017 - 05/2006
6Anemia
03/2012 - 05/2006
5Acute Lung Injury
01/2017 - 01/2007
4Newborn Respiratory Distress Syndrome
01/2022 - 12/2002
3Patent Ductus Arteriosus
01/2020 - 01/2012
3Respiratory Insufficiency (Respiratory Failure)
01/2018 - 07/2012
3Fibrosis (Cirrhosis)
01/2017 - 08/2014
3Neonatal Alloimmune Thrombocytopenia
01/2015 - 01/2006
3Hypertension (High Blood Pressure)
08/2014 - 10/2011
3Body Weight (Weight, Body)
06/2010 - 04/2009
2Pulmonary Arterial Hypertension
08/2015 - 02/2013
2Heart Injuries
08/2014 - 11/2010
2Erythema Infectiosum (Fifth Disease)
03/2012 - 01/2007
2Pulmonary Hypertension
01/2012 - 04/2009
2Birth Weight (Birth Weights)
10/2010 - 02/2009
2Hyperglycemia
07/2010 - 10/2003
2Edema (Dropsy)
01/2007 - 11/2004
1Sepsis (Septicemia)
12/2017
1Type 2 Diabetes Mellitus (MODY)
08/2015
1Thrombocytopenia (Thrombopenia)
01/2015
1Surfactant Dysfunction
01/2014
1Apnea
08/2013
1Fetal Growth Retardation (Intrauterine Growth Retardation)
08/2012
1Bipolar Disorder (Manic Depressive Psychosis)
06/2012
1Necrotizing Enterocolitis
01/2012

Drug/Important Bio-Agent (IBA)

18Surface-Active Agents (Surfactants)IBA
01/2022 - 01/2002
8Proteins (Proteins, Gene)FDA Link
01/2018 - 11/2004
8Messenger RNA (mRNA)IBA
01/2017 - 04/2006
7Peptides (Polypeptides)IBA
10/2021 - 12/2002
6FibrinIBA
08/2015 - 11/2004
5LipidsIBA
10/2021 - 01/2007
4Intravenous Immunoglobulins (IVIG)FDA Link
01/2015 - 01/2006
4Oxygen (Dioxygen)IBA
08/2013 - 11/2010
4Phospholipases (Phospholipase)IBA
12/2011 - 10/2007
4Immunoglobulin M (IgM)IBA
01/2007 - 05/2006
3IgA receptor (protein B)IBA
10/2021 - 12/2002
3Ibuprofen (Motrin)FDA LinkGeneric
01/2020 - 01/2012
3CytokinesIBA
01/2017 - 07/2007
3DNA (Deoxyribonucleic Acid)IBA
01/2007 - 03/2004
2AerosolsIBA
01/2022 - 12/2021
2Blood Glucose (Blood Sugar)IBA
08/2015 - 07/2010
2AngiotensinsIBA
08/2014 - 09/2013
2Vasoconstrictor AgentsIBA
09/2013 - 02/2013
2Endothelin-1 (Endothelin 1)IBA
02/2013 - 01/2007
2SteroidsIBA
08/2012 - 10/2010
2Secretory Phospholipases A2IBA
01/2010 - 11/2008
2EnzymesIBA
01/2010 - 11/2008
2Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2007 - 01/2007
1PowdersIBA
12/2021
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2018
1Leucine (L-Leucine)FDA Link
01/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018
1Pioglitazone (Actos)FDA Link
01/2018
1Blood Coagulation Factors (Coagulation Factor)IBA
01/2017
1Growth Differentiation Factor 2IBA
01/2017
1lysophosphatidic acidIBA
01/2017
1Indicators and Reagents (Reagents)IBA
01/2017
1LipopolysaccharidesIBA
01/2017
1Lysophosphatidic Acid ReceptorsIBA
01/2017
1Interleukin-6 (Interleukin 6)IBA
01/2017
1ChemokinesIBA
01/2017
1Therapeutic UsesIBA
01/2016
1Metformin (Glucophage)FDA LinkGeneric
08/2015
1Pharmaceutical PreparationsIBA
08/2015
1CollagenIBA
08/2015
1Type 2 Angiotensin ReceptorIBA
08/2014
1LigandsIBA
08/2014
1PD 123319IBA
08/2014
1calfactant (Infasurf)FDA Link
01/2014
1Angiotensin IIIBA
09/2013
1ambrisentanFDA Link
02/2013
1Endothelin Receptors (Endothelin Receptor)IBA
02/2013
1Naloxone (Narcan)FDA LinkGeneric
07/2012
1LithiumIBA
06/2012
1Antihypertensive Agents (Antihypertensives)IBA
01/2012
1Indomethacin (Indometacin)FDA LinkGeneric
01/2012
1piclamilastIBA
01/2012
1Phosphodiesterase 4 InhibitorsIBA
01/2012
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2012
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
01/2012

Therapy/Procedure

7Laser Therapy (Surgery, Laser)
06/2014 - 05/2006
5Therapeutics
01/2018 - 10/2003
5Intrauterine Blood Transfusion
03/2012 - 05/2006
3Platelet Transfusion (Blood Platelet Transfusions)
01/2015 - 01/2007
3Continuous Positive Airway Pressure
01/2014 - 02/2007
2Critical Care (Surgical Intensive Care)
12/2017 - 02/2008
2Lasers (Laser)
03/2007 - 11/2005
1Artificial Respiration (Mechanical Ventilation)
01/2022
1Noninvasive Ventilation
01/2022
1Perinatal Care
01/2018
1Resuscitation
07/2012